Chemoinformaics analysis of multifidol glucoside
| Molecular Weight | 372.37 | nRot | 6 |
| Heavy Atom Molecular Weight | 348.178 | nRig | 13 |
| Exact Molecular Weight | 372.142 | nRing | 2 |
| Solubility: LogS | -1.86 | nHRing | 1 |
| Solubility: LogP | -0.133 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 51.611 |
| nHD | 6 | BPOL | 28.417 |
| QED | 0.362 |
| Synth | 4.003 |
| Natural Product Likeliness | 2.293 |
| NR-PPAR-gamma | 0.117 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.761 |
| HIA | 0.777 |
| CACO-2 | -6.008 |
| MDCK | 0.000116292 |
| BBB | 0.612 |
| PPB | 0.767588 |
| VDSS | 0.936 |
| FU | 0.192963 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.071 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.156 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.534 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.17 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.081 |
| CL | 6.869 |
| T12 | 0.55 |
| hERG | 0.023 |
| Ames | 0.544 |
| ROA | 0.045 |
| SkinSen | 0.05 |
| Carcinogencity | 0.053 |
| EI | 0.015 |
| Respiratory | 0.059 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.673015 |